The Effectiveness of Pasteurized Goat Milk in the Treatment of Childhood Oral Ulcer Diseases
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Children with acute diseases with oral ulcers (not included PRESENTATIONS OF SLE, IBD or IMMUNOCOMPRMIZED STATES)will receive several doses (drinking or mouth rinsing) of either pasteurized goat milk or cow milk. Children will than be followed for length of the disease - signs and symptoms.
| Condition | Intervention | Phase |
|---|---|---|
|
Oral Ulcer |
Biological: Drinking or rinsing the mouth 2-3 times for 1 day Biological: Pasturlized cow milk |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Phase 1 1 Study Assesing the Benefit of Pasteurized Goat Milk in Reducing Disease Severity of Young Children With Oral Ulcer Diseases |
- Severity of disease [ Time Frame: 3 years ]
- Length of disease [ Time Frame: 3 years ]
| Enrollment: | 65 |
| Study Start Date: | January 2006 |
| Study Completion Date: | December 2007 |
| Primary Completion Date: | December 2007 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
55 children < 5 years with acute oral ulcer disease.
|
Biological: Drinking or rinsing the mouth 2-3 times for 1 day |
|
Placebo Comparator: 2
55 Children < 5 years with acute oral ulcer disease.
|
Biological: Pasturlized cow milk
Drinking or rinsing the mouth 2-3 times for one day.
|
Detailed Description:
A prospective randomized controlled study that will include 110 previously health 6months - 5 years children (55 in each group) with acute oral ulcer disease (< 48 hours). Children will receive several doses (drinking or mouth rinsing) of either pasteurized goat milk or cow milk. Children will than be followed for length of the disease - sings and symptoms by questioner to parents, and physical examination by there physicians. .
Eligibility| Ages Eligible for Study: | 6 Months to 5 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Age > 6 months or < 5 years.
- Acute (< 48 hours) oral ulcer disease.
- > 5 ulcers.
- Cooperative parents .
- Signing inform consent.
Exclusion Criteria:
- All types of immunosuppression, IBD, SLE, recurrent oral ulcer, disease > 48 hours, age , 6 < months or > 5 years.
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Dan Miron MD, HaEmek Medical Center, Israel |
| ClinicalTrials.gov Identifier: | NCT00333749 History of Changes |
| Other Study ID Numbers: | 3870505 |
| Study First Received: | January 13, 2006 |
| Last Updated: | September 3, 2009 |
| Health Authority: | Israel: Ethics Commission |
Keywords provided by HaEmek Medical Center, Israel:
|
children |
Additional relevant MeSH terms:
|
Peptic Ulcer Ulcer Oral Ulcer Duodenal Diseases Intestinal Diseases Gastrointestinal Diseases |
Digestive System Diseases Stomach Diseases Pathologic Processes Mouth Diseases Stomatognathic Diseases |
ClinicalTrials.gov processed this record on May 16, 2013